Yakira Capital Management Inc. purchased a new stake in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 8,499 shares of the company’s stock, valued at approximately $322,000.
A number of other institutional investors have also modified their holdings of the company. Raymond James Financial Inc. bought a new position in shares of BlackRock Health Sciences Trust during the 4th quarter worth approximately $3,250,000. Janney Montgomery Scott LLC grew its holdings in BlackRock Health Sciences Trust by 40.5% in the fourth quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after purchasing an additional 9,455 shares during the last quarter. Hara Capital LLC acquired a new position in shares of BlackRock Health Sciences Trust during the fourth quarter worth $832,000. Wolverine Asset Management LLC lifted its holdings in shares of BlackRock Health Sciences Trust by 29.1% during the 4th quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock valued at $4,191,000 after purchasing an additional 24,928 shares during the last quarter. Finally, HBK Sorce Advisory LLC boosted its position in shares of BlackRock Health Sciences Trust by 14.8% in the 4th quarter. HBK Sorce Advisory LLC now owns 8,194 shares of the company’s stock worth $311,000 after purchasing an additional 1,057 shares in the last quarter.
BlackRock Health Sciences Trust Stock Down 4.8 %
Shares of NYSE:BME opened at $36.32 on Friday. The business’s 50-day moving average is $39.68 and its 200 day moving average is $39.84. BlackRock Health Sciences Trust has a 1 year low of $36.24 and a 1 year high of $42.64.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- What is Insider Trading? What You Can Learn from Insider Trading
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Should You Invest in Penny Stocks?
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- The Basics of Support and Resistance
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.